Emflaza oral suspension — Medica
Duchenne muscular dystrophy (DMD)
Preferred products
- generic deflazacort tablets
Initial criteria
- Patient meets the standard Muscular Dystrophy – Deflazacort Prior Authorization Policy criteria
- Patient has tried a Preferred Product (generic deflazacort tablets) OR meets exception criteria for Non‑Preferred Product
- age ≥ 2 years
Approval duration
1 year